Works matching IS 15430790 AND DT 2021 AND VI 19
Results: 255
Optimizing Administration of Third-Line Treatment in Metastatic Colorectal Cancer: Q&A.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 16
- By:
- Publication type:
- Article
Recent Study Data in Third-Line Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 13
- By:
- Publication type:
- Article
Measures to Mitigate Treatment-Related Toxicities in Third-Line Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 6
- By:
- Publication type:
- Article
Third-Line Treatment Strategies in Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 2
- By:
- Publication type:
- Article
The Use of Immunotherapy in Triple-Negative Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 770
- By:
- Publication type:
- Article
Umbralisib and Ublituximab: An Upcoming Regimen for Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 768
- By:
- Publication type:
- Article
Update on Adjuvant Therapy in Late-Stage Resected Melanoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 753
- By:
- Publication type:
- Article
Nursing Help Wanted.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 738
- By:
- Publication type:
- Article
Refining Dosing Strategies: Lessons From Singapore's Health Care System.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 756
- By:
- Publication type:
- Article
Evolving Standards of Care for Neoadjuvant and Adjuvant Therapy in Esophageal, Gastroesophageal Junction, and Gastric Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 784
- By:
- Publication type:
- Article
Biomarker Analysis of Men With Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer Treated With Pembrolizumab + Enzalutamide in KEYNOTE-199.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 15
- Publication type:
- Article
Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 764
- By:
- Publication type:
- Article
Highlights in Prostate Cancer From the 2021 European Society for Medical Oncology Congress and the 2021 American Urological Association Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 19
- By:
- Publication type:
- Article
Final Overall Survival Analysis From ARCHES: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Enzalutamide Plus Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 17
- Publication type:
- Article
Health-Related Quality of Life, Pain, and Safety Outcomes in the Phase III VISION Study of <sup>177</sup>Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 16
- Publication type:
- Article
The Emergence of Targetable Pathways in Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 20, p. 774
- By:
- Publication type:
- Article
Time Course Profile of Adverse Events of Interest and Serious Adverse Events With Darolutamide in the ARAMIS Trial.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 13
- Publication type:
- Article
Abiraterone Acetate Plus Prednisolone With or Without Enzalutamide Added to Androgen Deprivation Therapy (ADT) Compared to ADT Alone for Men With High-Risk Nonmetastatic Prostate Cancer: Combined Analysis From Two Comparisons in the STAMPEDE Platform Protocol
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 12
- Publication type:
- Article
Impact of Darolutamide on Local Symptoms in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 11
- Publication type:
- Article
Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of Expanded Cohort 6 of the COSMIC-021 Study.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 9
- Publication type:
- Article
Darolutamide Maintenance in Metastatic Castration-Resistant Prostate Cancer Previously Treated With Novel Hormonal Agents and Nonprogressive Disease After Subsequent Treatment With a Taxane: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial (SAKK 08/16)
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 7
- Publication type:
- Article
Objective Computerized Cognitive Assessment in Men With Metastatic Castrate-Resistant Prostate Cancer Randomly Receiving Darolutamide or Enzalutamide in the ODENZA Trial.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 6
- Publication type:
- Article
How to Choose Second-Line Treatment for Hepatocellular Carcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 726
- Publication type:
- Article
New Data for Sacituzumab Govitecan-hziy in the Treatment of Metastatic Triple-Negative Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 723
- Publication type:
- Article
Total Neoadjuvant Therapy Approach in Rectal Adenocarcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 711
- By:
- Publication type:
- Article
The Role of AR-V7 Testing in the Management of Metastatic CRPC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 694
- Publication type:
- Article
The Use of ADAMTS13 Assays in Thrombotic Microangiopathies.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 687
- Publication type:
- Article
The Evolving Use of CAR T-Cell Therapy in Follicular Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 684
- Publication type:
- Article
To Boost or Not to Boost?
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. 670
- By:
- Publication type:
- Article
DA-R-EPOCH vs R-CHOP in DLBCL: How Do We Choose?
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. e698
- By:
- Publication type:
- Article
How Quality of Life Can Inform Management Decisions in Later-Line Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 1
- By:
- Publication type:
- Article
Evolving Strategies for the Management of Transformed Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 624
- By:
- Publication type:
- Article
Immunotherapy for Small Cell Lung Cancer: Established Applications and Novel Approaches.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 654
- By:
- Publication type:
- Article
Immunotherapy in Esophagogastric Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 639
- By:
- Publication type:
- Article
Lessons Learned From the CAPTIVATE Trial of Ibrutinib Plus Venetoclax in CLL.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 636
- By:
- Publication type:
- Article
Neoadjuvant and Adjuvant Approaches in Surgically Resectable NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 631
- By:
- Publication type:
- Article
How Quality of Life Can Help Guide Selection of Androgen Receptor Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 627
- By:
- Publication type:
- Article
Addressing the Racial Gap in Health Care.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 610
- By:
- Publication type:
- Article
Highlights in Colorectal Cancer From the 2021 American Society of Clinical Oncology Annual Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 11
- By:
- Publication type:
- Article
Regorafenib in Patients With Relapsed Advanced or Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 10
- Publication type:
- Article
The TRUSTY Study: A Randomized Phase 2/3 Study of Trifluridine/Tipiracil Plus Bevacizumab Versus Irinotecan and Fluoropyrimidine Plus Bevacizumab as Second-Line Treatment in Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 9
- Publication type:
- Article
Preliminary Results of a Phase 1b Study of Fruquintinib Plus Sintilimab in Advanced Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 8
- Publication type:
- Article
Regorafenib Combined With PD-1 Inhibition as Salvage Treatment and in a Real-World Study of Patients with Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 7
- Publication type:
- Article
LEAP-005: A Phase 2 Multicohort Study of Lenvatinib Plus Pembrolizumab in Patients With Previously Treated Selected Solid Tumors--Results From the Colorectal Cancer Cohort.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 6
- Publication type:
- Article
Phase 1b/2 Open-Label, Randomized Evaluation of Atezolizumab + Imprime PGG + Bevacizumab vs Regorafenib in MORPHEUS: Microsatellite-Stable Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 5
- Publication type:
- Article
Single-Arm, Phase 2 Study of Regorafenib Plus Nivolumab in Patients With Mismatch Repair Proficient/Microsatellite Stable Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 3
- Publication type:
- Article
Final Overall Survival for the Phase III KN177 Study: Pembrolizumab Versus Chemotherapy in Microsatellite Instability-High/Mismatch Repair Deficient Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 2
- Publication type:
- Article
Now for Something Completely Different.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 9, p. 542
- By:
- Publication type:
- Article
Management of Well-Differentiated Neuroendocrine Tumors.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 9, p. 582
- By:
- Publication type:
- Article
The Use of Neoadjuvant Therapy to Further Personalize Breast Cancer Treatment.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 9, p. 569
- By:
- Publication type:
- Article